Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples